The European Commission approves label expansion of Pfizer’s (PFE) Lorviqua as a first-line treatment for ALK-positive non-small cell lung cancer.
Business, Services And Guides For Music Labels
Business, Services And Guides For Music Labels
The European Commission approves label expansion of Pfizer’s (PFE) Lorviqua as a first-line treatment for ALK-positive non-small cell lung cancer.